KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Goodwill & Intangibles (2018 - 2025)

Aurinia Pharmaceuticals' Goodwill & Intangibles history spans 7 years, with the latest figure at $3.8 million for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 13.64% year-over-year to $3.8 million; the TTM value through Dec 2025 reached $3.8 million, down 13.64%, while the annual FY2025 figure was $3.8 million, 13.64% down from the prior year.
  • Goodwill & Intangibles reached $3.8 million in Q4 2025 per AUPH's latest filing, down from $3.9 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $9.9 million in Q1 2021 to a low of $3.8 million in Q4 2025.
  • Average Goodwill & Intangibles over 5 years is $6.1 million, with a median of $5.5 million recorded in 2023.
  • Peak YoY movement for Goodwill & Intangibles: dropped 23.55% in 2022, then dropped 12.44% in 2025.
  • A 5-year view of Goodwill & Intangibles shows it stood at $8.4 million in 2021, then fell by 23.55% to $6.4 million in 2022, then fell by 22.54% to $5.0 million in 2023, then fell by 12.5% to $4.4 million in 2024, then fell by 13.64% to $3.8 million in 2025.
  • Per Business Quant, the three most recent readings for AUPH's Goodwill & Intangibles are $3.8 million (Q4 2025), $3.9 million (Q3 2025), and $4.0 million (Q2 2025).